Aarti Industries Limited vs Divi's Laboratories Limited
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Aarti Industries Limited (Specialty chemicals) and Divi's Laboratories Limited (Pharmaceuticals - APIs and custom synthesis) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, Divi's Laboratories Limited leads on Revenue (approx.).
Divi's Laboratories Limited leads on Revenue (approx.).
Head-to-head highlights
| Metric | Aarti Industries Limited | Divi's Laboratories Limited | Basis |
|---|---|---|---|
| Revenue (approx.) | Approximately ₹6,000–7,500 crore | Approximately ₹7,000-8,500 crore | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Aarti Industries Limited
Specialty chemicals · India
Aarti Industries Limited is an Indian specialty chemicals manufacturer focused on benzene- and toluene-based derivatives and other value-added intermediates. The company serves end markets such as agrochemicals, polymers, dyes, pigments, additives, and pharmaceuticals intermediates after the demerger of its pharma-focused business.
Verified financials
No source-verified financials available.
Strengths
- Strong expertise in complex aromatic chemistry
- Integrated manufacturing capabilities across multiple chemical processes
- Established relationships with domestic and international customers
- Diversified exposure across several end-use industries
Weaknesses
- Exposure to cyclical demand in chemicals and export markets
- High capital intensity and long project gestation periods
- Margin sensitivity to raw material and energy price movements
- Regulatory and environmental compliance burden
Opportunities
- Global supply-chain diversification away from China
- Growth in agrochemicals, polymers, and specialty intermediates
- Expansion into higher-value custom synthesis products
- Operational benefits from process optimization and backward integration
Threats
- Pricing pressure from domestic and overseas competitors
- Volatility in crude-linked feedstock costs
- Environmental, safety, and regulatory disruptions
- Slowdown in global specialty chemical demand
Divi's Laboratories Limited
Pharmaceuticals - APIs and custom synthesis · India
Divi's Laboratories Limited is an Indian pharmaceutical company focused on manufacturing active pharmaceutical ingredients, intermediates, and custom-synthesis products for global pharmaceutical customers. The company is export-oriented and serves regulated markets with large-scale chemistry, process development, and manufacturing capabilities.
Verified financials
No source-verified financials available.
Strengths
- Strong capabilities in large-scale API and intermediate manufacturing
- Established export presence in regulated markets
- Long-standing focus on custom synthesis and process chemistry
- Manufacturing scale and backward-integration capabilities
Weaknesses
- Revenue can be exposed to concentration in select products or customers
- Dependence on regulatory approvals and inspections
- High capital intensity for capacity expansion
- Exposure to currency movements and raw material cost volatility
Opportunities
- Growth in pharmaceutical outsourcing and CDMO demand
- Supply-chain diversification away from single-country sourcing
- Expansion into higher-value complex APIs and custom synthesis
- Increasing demand for nutraceutical and specialty ingredients
Threats
- Price pressure in generic APIs
- Regulatory observations or import alerts affecting operations
- Competition from Indian and Chinese manufacturers
- Environmental and compliance-related operating constraints
Frequently asked
Answered from source-verified figures on this page.
Aarti Industries Limited vs Divi's Laboratories Limited: which company leads overall?
Divi's Laboratories Limited leads on Revenue (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
Global Radiopharmaceuticals and Theranostics Market — Intelligence Report
Global Sustainable Chemicals Market — Green Chemistry, Circular Economy & Industry Transformation Intelligence Report
Europe Sustainable Materials Market — Circular Materials, Decarbonization & Growth Opportunities
Global Semiconductor Chemicals Market — Electronic Chemicals, Manufacturing Demand & Technology Outlook
AI Analyst
Insights and answers generated live from Aarti Industries Limited vs Divi's Laboratories Limited's verified data. Modeled estimates — not investment advice.